Miconazolnitraat Teva (Miconazole Nitrate)

Miconazole nitrate blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for converting lanosterol to ergosterol, a key component of fungal cell membranes. By inhibiting ergosterol synthesis, the drug disrupts membrane integrity, increasing permeability and leading to fungal cell death, thereby clearing the infection.

The specific dosing regimen for Miconazolnitraat Teva is determined by the prescribing healthcare professional based on the infection type, severity, patient age, and treatment site. The prescriber will provide instructions on the amount to apply, frequency, and duration of therapy.

Safety data for topical miconazole nitrate in pregnancy and lactation are limited. Healthcare providers generally weigh the benefits against potential risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician to determine if it is appropriate for their situation.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Miconazolnitraat Teva belongs to the azole class, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, azoles like miconazole have a slightly slower onset but are effective for a wide range of skin infections and are available in various topical formulations, making them versatile for different clinical scenarios.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

The medication is applied topically to clean, dry skin. A thin layer should be spread over the affected area and surrounding skin, usually twice daily or as directed by the prescriber. Hands should be washed after application, and the treated area should be allowed to dry before covering with clothing or bandages.

While generally well tolerated, serious adverse reactions can include severe contact dermatitis, extensive skin ulceration, or an allergic response characterized by swelling, hives, or difficulty breathing. If any of these occur, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to miconazole nitrate or any other component of the formulation should avoid using the product. It should also not be applied to large areas of broken skin, mucous membranes, or the eyes, and caution is advised in patients with a history of severe skin reactions.